Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Tonkin

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Drugs & Aging|October 21, 2003
Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE)Mark Nelson, Christopher Reid, Lawrence Beilin, et al.
Journal of Epidemiology and Community Health|October 9, 2013
A systematic review of air pollution and incidence of out-of-hospital cardiac arrestTiew-Hwa Katherine Teng, Teresa A Williams, Alexandra Bremner, et al.
European Journal of Preventive Cardiology|December 12, 2018
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspectiveElla Zomer, Si Si, Thomas R Hird, et al.
Atherosclerosis|October 13, 2005
Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID studyRoland Stocker, Christine Pollicino, Craig A Gay, et al.
Archives of Gerontology and Geriatrics|July 4, 2025
Social determinants of health clusters and risk of cardiovascular disease among community-dwelling older men and women: A clustering and causal machine learning approachAchamyeleh Birhanu Teshale, Htet Lin Htun, Alice J Owen, et al.
The Canadian Journal of Cardiology|June 13, 2025
Frailty risk after a cardiovascular event among community-dwelling older people: Influence of sociodemographic, polypharmacy and pre-event frailtyAung Zaw Zaw Phyo, Andrew Tonkin, Sara E Espinoza, et al.
The Canadian Journal of Cardiology|December 13, 2025
Transitions From Frailty States to Cardiovascular Events: An 11-Year Prospective Study of Community-Dwelling Older PeopleAung Zaw Zaw Phyo, Andrew Tonkin, Sara E Espinoza, et al.
Environmental Pollution (Barking, Essex : 1987)|May 13, 2019
Accumulation and toxicity of monoaromatic petroleum hydrocarbons in early life stages of cod and haddockLisbet Sørensen, Bjørn Henrik Hansen, Julia Farkas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Expanded statistical analysis plan for legacy and long-term effects of aspirin in the ASPREE-XT observational follow-up study of participants in the ASPREE randomized trialRory Wolfe, Jonathan Broder, Andrew Chan, et al.
Journal of Aging and Health|April 12, 2022
The Association of Dispositional Optimism and Pessimism With Cardiovascular Disease Events in Older Adults: A Prospective Cohort StudyHeather Craig, Joanne Ryan, Rosanne Freak-Poli, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Drugs & Aging|October 21, 2003
Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE)Mark Nelson, Christopher Reid, Lawrence Beilin, et al.
Journal of Epidemiology and Community Health|October 9, 2013
A systematic review of air pollution and incidence of out-of-hospital cardiac arrestTiew-Hwa Katherine Teng, Teresa A Williams, Alexandra Bremner, et al.
European Journal of Preventive Cardiology|December 12, 2018
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspectiveElla Zomer, Si Si, Thomas R Hird, et al.
Atherosclerosis|October 13, 2005
Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID studyRoland Stocker, Christine Pollicino, Craig A Gay, et al.
Archives of Gerontology and Geriatrics|July 4, 2025
Social determinants of health clusters and risk of cardiovascular disease among community-dwelling older men and women: A clustering and causal machine learning approachAchamyeleh Birhanu Teshale, Htet Lin Htun, Alice J Owen, et al.
The Canadian Journal of Cardiology|June 13, 2025
Frailty risk after a cardiovascular event among community-dwelling older people: Influence of sociodemographic, polypharmacy and pre-event frailtyAung Zaw Zaw Phyo, Andrew Tonkin, Sara E Espinoza, et al.
The Canadian Journal of Cardiology|December 13, 2025
Transitions From Frailty States to Cardiovascular Events: An 11-Year Prospective Study of Community-Dwelling Older PeopleAung Zaw Zaw Phyo, Andrew Tonkin, Sara E Espinoza, et al.
Environmental Pollution (Barking, Essex : 1987)|May 13, 2019
Accumulation and toxicity of monoaromatic petroleum hydrocarbons in early life stages of cod and haddockLisbet Sørensen, Bjørn Henrik Hansen, Julia Farkas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Expanded statistical analysis plan for legacy and long-term effects of aspirin in the ASPREE-XT observational follow-up study of participants in the ASPREE randomized trialRory Wolfe, Jonathan Broder, Andrew Chan, et al.
Journal of Aging and Health|April 12, 2022
The Association of Dispositional Optimism and Pessimism With Cardiovascular Disease Events in Older Adults: A Prospective Cohort StudyHeather Craig, Joanne Ryan, Rosanne Freak-Poli, et al.
Pageof 17